Changes in oxygenation following steroid administration in patients diagnosed with e-cigarette, or vaping, associated lung injury (EVALI)

D. Blagev (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), S. Callahan (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), D. Collingridge (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), M. Lanspa (Salt Lake City, United States of America)

Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Blagev (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), S. Callahan (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), D. Collingridge (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), M. Lanspa (Salt Lake City, United States of America). Changes in oxygenation following steroid administration in patients diagnosed with e-cigarette, or vaping, associated lung injury (EVALI). 1872

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Shifting demographics of patients diagnosed with E-cigarette or vaping associated lung injury (EVALI)
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Prevalence of diagnoses and comorbid conditions in patients with e-cigarette, or vaping, associated lung injury (EVALI)
Source: Virtual Congress 2020 – Air pollution considerations
Year: 2020


When to start surfactant therapy (ST-therapy) of acute lung injury?
Source: Eur Respir J 2001; 18: Suppl. 33, 7s
Year: 2001

Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Source: Eur Respir J 2009; 33: 634-645
Year: 2009



A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Source: Eur Respir J 2016; 47: 651-654
Year: 2016


No man is an island: e-cigarette, or vaping, associated lung injury in Europe
Source: Eur Respir J, 55 (2) 1902419; 10.1183/13993003.02419-2019
Year: 2020



Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation
Source: Eur Respir J 2003; 22: 47S-56S
Year: 2003



Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Acute lung injury as a possible adverse drug reaction related to gefitinib
Source: Eur Respir J 2002 Jan 01;22(1):179-181
Year: 2003



Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=281
Year: 2006

The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD)
Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure
Year: 2009


Characteristics of glucose metabolism in patients receiving glucocorticoid therapy for interstitial lung disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017

A novel approach for optimal lung recruitment in acute lung injury
Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury
Year: 2005


Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012



The use of a new intra-pulmonary percussive ventilation (IPPV) device to aid lung volume recruitment (LVR) and secretion clearance in a patient with C1 spinal cord injury (SCI)
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005